Mesoblast Limited (MEOBF)
USD 1.37
(-52.76%)
USD 1.37
(-52.76%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 5.9 Million | 7.5 Million | 10.21 Million | 7.45 Million | 32.15 Million | 16.72 Million |
| Cost of Revenue | 41.07 Million | 27.45 Million | 29.26 Million | 32.92 Million | 25.99 Million | 15.07 Million |
| Gross Profit | -35.16 Million | -19.95 Million | -19.05 Million | -25.47 Million | 6.16 Million | 1.65 Million |
| Operating Expenses | 5.9 Million | 76.79 Million | 90.78 Million | 115.05 Million | 107.56 Million | 97.88 Million |
| Selling, General and Administrative Expenses | 39.34 Million | 53.1 Million | 57.96 Million | 63.58 Million | 50.91 Million | 36.98 Million |
| Research and Development Expenses | 25.35 Million | 27.18 Million | 32.81 Million | 53.01 Million | 56.18 Million | 59.81 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 90.04 Million | 76.79 Million | 90.78 Million | 115.05 Million | 107.56 Million | 97.88 Million |
| Operating Income | -84.14 Million | -69.13 Million | -80.95 Million | -111.86 Million | -79.07 Million | -83.3 Million |
| Interest Expense | 20.65 Million | 19.44 Million | 16.9 Million | 10.71 Million | 13.33 Million | 11.32 Million |
| Income Tax Expense | -194.29 Thousand | -212 Thousand | -239 Thousand | -819 Thousand | -9.41 Million | -8.95 Million |
| Earnings before Tax | -89.66 Million | -82.1 Million | -91.58 Million | -99.63 Million | -87.35 Million | -98.75 Million |
| Net Income | -87.95 Million | -81.88 Million | -91.34 Million | -98.81 Million | -77.94 Million | -89.79 Million |
| Earnings Per Share Basic | -0.09 | -0.11 | -0.13 | -0.15 | -0.14 | -0.17 |
| Earnings Per Share Diluted | -0.09 | -0.11 | -0.13 | -0.15 | -0.14 | -0.17 |
| Weighted Average Shares Outstanding | 986.7 Million | 779.45 Million | 684.38 Million | 638.15 Million | 557.74 Million | 521.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 986.7 Million | 779.45 Million | 684.38 Million | 638.15 Million | 557.74 Million | 521.41 Million |
| Gross Margin | -5.96 | -2.66 | -1.87 | -3.42 | 0.19 | 0.10 |
| EBIT Margin | -10.57 | -8.67 | -7.50 | -14.43 | -2.34 | -4.85 |
| Profit Margin | -14.90 | -10.92 | -8.95 | -13.25 | -2.42 | -5.37 |
| EBITDA | -62.38 Million | -60.77 Million | -66.52 Million | -79.93 Million | -70.83 Million | -83.31 Million |
| Earnings Before Tax Margin | -14.26 | -9.22 | -7.93 | -15.00 | -2.46 | -4.98 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 6 Million | 1.25 Million | 1.25 Million | 1.69 Million | 1.69 Million | 7.5 Million |
| Cost of Revenue | 15.98 Million | 10.83 Million | 10.83 Million | 9.69 Million | 9.69 Million | 27.45 Million |
| Gross Profit | -9.98 Million | -9.58 Million | -9.58 Million | -8 Million | -8 Million | -19.95 Million |
| Operating Expenses | 49.82 Million | 12.42 Million | 12.42 Million | 12.06 Million | 3.21 Million | 76.79 Million |
| Selling, General and Administrative Expenses | - | 6.07 Million | 6.07 Million | 5.74 Million | 5.74 Million | - |
| Research and Development Expenses | - | 6.35 Million | 6.35 Million | 6.32 Million | 6.32 Million | - |
| Other Expenses | -37.63 Thousand | - | - | - | - | - |
| Cost and Expenses | 65.81 Million | 23.26 Million | 23.26 Million | 21.76 Million | 12.91 Million | 76.79 Million |
| Operating Income | -59.8 Million | -22 Million | -22 Million | -20.06 Million | -13.29 Million | -69.13 Million |
| Interest Expense | 20.65 Million | - | - | - | - | 19.44 Million |
| Income Tax Expense | -194.29 Thousand | 44.5 Thousand | 44.5 Thousand | 51 Thousand | 51 Thousand | -212 Thousand |
| Earnings before Tax | -89.66 Million | -27.75 Million | -27.75 Million | -16.32 Million | -16.32 Million | -82.1 Million |
| Net Income | -89.47 Million | -27.7 Million | -27.7 Million | -16.26 Million | -16.26 Million | -81.88 Million |
| Earnings Per Share Basic | - | -0.02 | -0.02 | -0.02 | -0.02 | - |
| Earnings Per Share Diluted | - | -0.02 | -0.02 | -0.02 | -0.02 | - |
| Weighted Average Shares Outstanding | 986.7 Million | 1.12 Billion | 1.12 Billion | 851.49 Million | 851.49 Million | 779.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 986.7 Million | 1.12 Billion | 1.12 Billion | 851.46 Million | 851.46 Million | 779.45 Million |
| Gross Margin | -1.66 | -7.62 | -7.62 | -4.72 | -4.72 | -2.66 |
| EBIT Margin | - | -12.14 | -12.14 | -7.54 | -7.54 | - |
| Profit Margin | -14.90 | -22.04 | -22.04 | -9.60 | -9.60 | -10.92 |
| EBITDA | - | -15.25 Million | -15.25 Million | -12.78 Million | -12.78 Million | - |
| Earnings Before Tax Margin | -9.96 | -17.51 | -17.51 | -11.85 | -7.85 | -9.22 |
6482
301000
BCPC
ESSA
0QIH
9110